Bemarituzumab
FPA144-004 Phase 2
Phase 2 mab completed
Quick answer
Bemarituzumab for Gastric Cancer is a Phase 2 program (mab) at Prime Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Prime Medicine
- Indication
- Gastric Cancer
- Phase
- Phase 2
- Modality
- mab
- Status
- completed